Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 44

    1.

    Xenoestrogens: the emerging story of bisphenol a.

    Ben-Jonathan N, Steinmetz R.

    Trends Endocrinol Metab. 1998 Apr;9(3):124-8.PMID: 18406253 [PubMed - in process]Related articles

    2.

    Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes.

    Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S, Kohen F.

    J Immunol. 2003 Jan 1;170(1):114-22.PMID: 12496390 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type.

    Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, Inoue S, Muramatsu M, Momoeda M, Taketani Y.

    Endocr J. 2002 Aug;49(4):465-71.PMID: 12402979 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Promotion of lupus in NZB x NZWF1 mice by plasmids encoding interferon (IFN)-gamma but not by those encoding interleukin (IL)-4.

    Hasegawa K, Hayashi T, Maeda K.

    J Comp Pathol. 2002 Jul;127(1):1-6.PMID: 12354539 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.

    Yoshida H, Satoh M, Behney KM, Lee CG, Richards HB, Shaheen VM, Yang JQ, Singh RR, Reeves WH.

    Arthritis Rheum. 2002 Aug;46(8):2235-44.PMID: 12209530 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB.

    Quesada I, Fuentes E, Viso-León MC, Soria B, Ripoll C, Nadal A.

    FASEB J. 2002 Oct;16(12):1671-3. Epub 2002 Aug 21.PMID: 12207000 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    IL-10 regulates murine lupus.

    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J.

    J Immunol. 2002 Aug 15;169(4):2148-55.PMID: 12165544 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Estrogen receptor alpha in mouse splenic lymphocytes: possible involvement in immunity.

    Sakazaki H, Ueno H, Nakamuro K.

    Toxicol Lett. 2002 Jul 21;133(2-3):221-9.PMID: 12119130 [PubMed - indexed for MEDLINE]Related articles

    9.

    Estrogen alters thresholds for B cell apoptosis and activation.

    Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B.

    J Clin Invest. 2002 Jun;109(12):1625-33.PMID: 12070310 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Histone deacetylation inhibits IL4 gene expression in T cells.

    Valapour M, Guo J, Schroeder JT, Keen J, Cianferoni A, Casolaro V, Georas SN.

    J Allergy Clin Immunol. 2002 Feb;109(2):238-45.PMID: 11842291 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice.

    Karpuzoglu-Sahin E, Zhi-Jun Y, Lengi A, Sriranganathan N, Ansar Ahmed S.

    Cytokine. 2001 May 21;14(4):208-17.PMID: 11448120 [PubMed - indexed for MEDLINE]Related articles

    12.

    Interleukin-10 and the interleukin-10 receptor.

    Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A.

    Annu Rev Immunol. 2001;19:683-765. Review.PMID: 11244051 [PubMed - indexed for MEDLINE]Related articles

    13.

    Endocrine disrupters. Panel cautiously confirms low-dose effects.

    Kaiser J.

    Science. 2000 Oct 27;290(5492):695-7.PMID: 11184192 [PubMed - indexed for MEDLINE]Related articles

    14.

    Estrogen receptor pathways to AP-1.

    Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P.

    J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):311-7. Review.PMID: 11162939 [PubMed - indexed for MEDLINE]Related articles

    15.

    Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

    Csiszár A, Nagy G, Gergely P, Pozsonyi T, Pócsik E.

    Clin Exp Immunol. 2000 Dec;122(3):464-70.PMID: 11122256 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells.

    Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK.

    Endocrinology. 2000 Sep;141(9):3403-11.PMID: 10965913 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals.

    Gupta C.

    Proc Soc Exp Biol Med. 2000 Jun;224(2):61-8.PMID: 10806412 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.

    Zeng D, Lee MK, Tung J, Brendolan A, Strober S.

    J Immunol. 2000 May 15;164(10):5000-4.PMID: 10799851 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells.

    Inadera H, Sekiya T, Yoshimura T, Matsushima K.

    Endocrinology. 2000 Jan;141(1):50-9.PMID: 10614622 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    In vitro effect of the resin component bisphenol A on substrate adherence capacity of macrophages.

    Segura JJ, Jiménez-Rubio A, Pulgar R, Olea N, Guerrero JM, Calvo JR.

    J Endod. 1999 May;25(5):341-4.PMID: 10530258 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data